Podcast in English
Text size
Bulgarian National Radio © 2024 All Rights Reserved

Bulgaria starts production of medicines for COVID-19 treatment

Photo: Archive

Bulgaria will start the production of the medications chloroquine and hydroxychloroquine known for treatment of malaria. There has been medical evidence that they give good results in the treatment of COVID-19. The technology has already been mastered. The components needed for the production have already been ordered. The first 5,000 packages of the drugs will be available by April 20. Bulgaria now expects delivery of the same medications from China, Taiwan and India, but there is no guarantee that the contracts will be complied with.

These medicines are not authorized for sale in drugstores in Bulgaria. They will only be delivered to hospitals for the treatment of coronavirus patients.



Последвайте ни и в Google News Showcase, за да научите най-важното от деня!
Listen to the daily news from Bulgaria presented in "Bulgaria Today" podcast, available in Spotify.

More from category

Supreme Administrative Court has once again failed to elect chair

There are no candidates for the position of chair of the Supreme Administrative Court (SAC) , BTA has reported. The plenum of the Supreme Judicial Council held a meeting in an attempt to elect head of the institution. The procedure..

published on 11/28/24 10:21 AM

Bulgarians will travel to China without visas

The People's Republic of China is introducing a visa-free regime for holders of Bulgarian passports for business purposes, tourism, visiting relatives or friends, official visits or transit, for no more than 30 days. The Situation..

published on 11/28/24 8:50 AM

New attempt to elect speaker 18 days after the opening of the 51st National Assembly

Bulgarian MPs are meeting today for the seventh time in an attempt to elect a speaker of the 51st National Assembly after the first six failed to produce a result. This is how the first session of the new parliament, which began on November 11, continues..

published on 11/28/24 7:40 AM